2015
DOI: 10.1387/ijdb.150213gb
|View full text |Cite
|
Sign up to set email alerts
|

HA14-1 potentiates apoptosis in B-cell cancer cells sensitive to a peptide disrupting IP3 receptor / Bcl-2 complexes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
3

Relationship

3
6

Authors

Journals

citations
Cited by 21 publications
(16 citation statements)
references
References 34 publications
1
15
0
Order By: Relevance
“…BIRD-2 disrupts endogenous Bcl-2/IP 3 R complexes, thereby triggering Ca 2+ -driven apoptosis in different malignancies, including CLL [18,20,30], DLBCL [20], multiple myeloma [31], follicular lymphoma [31], and small cell lung cell carcinoma [32]. DLBCL cells displayed a varying sensitivity to BIRD-2, which correlated to the expression levels of IP 3 R2 [20].…”
Section: Discussionmentioning
confidence: 99%
“…BIRD-2 disrupts endogenous Bcl-2/IP 3 R complexes, thereby triggering Ca 2+ -driven apoptosis in different malignancies, including CLL [18,20,30], DLBCL [20], multiple myeloma [31], follicular lymphoma [31], and small cell lung cell carcinoma [32]. DLBCL cells displayed a varying sensitivity to BIRD-2, which correlated to the expression levels of IP 3 R2 [20].…”
Section: Discussionmentioning
confidence: 99%
“…Dysregulated expression of Bcl-2 has been described in various cancers, such as chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DL-BCL), non-small cell lung carcinoma, multiple myeloma, follicular lymphoma and small cell lung cancer (Packham, 1998). BIRD2, a Bcl-2/IP3R inhibitor, has shown promising results in the treatment of B-cell cancers (Akl et al, 2015), small cell lung cancer, CLL, multiple myeloma and follicular lymphoma , Lavik et al, 2015. Bcl-XL is another oncogene belonging to the Bcl-2 family that is frequently overexpressed in tumors.…”
Section: Cancermentioning
confidence: 99%
“…Currently, the most promising peptide allowing for IP3R modulation through Bcl-2 is the Bcl-2-IP3R disrupter-2 (BIRD-2). As a BH4 mimetic, BIRD-2 targets the BH4 domain of Bcl-2, preventing its interaction with IP3R and inducing apoptosis through IP3R signaling [121,122]. Interestingly, a recent study showed that both ER and extracellular calcium content are crucial to determine the efficiency of BIRD-2, as it is able to switch IP3R signaling from pro-survival to pro-apoptotic [123].…”
Section: Inositol 145-trisphosphate Receptor (Ip3r)mentioning
confidence: 99%